Skip to main content

How Semaglutide Lowers Blood Sugar

 Understanding the Benefits of Semaglutide for Diabetes Management with Levemir FlexTouch

Semaglutide is renowned for its powerful hypoglycemic effects, making it a top choice for managing diabetes. As a GLP-1 receptor agonist, semaglutide enhances insulin secretion and suppresses glucagon secretion in a glucose-dependent manner by activating the GLP-1 receptor. It also increases glucose uptake in muscle and adipose tissue while inhibiting hepatic glucose production, delays gastric emptying, and suppresses appetite.

Clinical Efficacy of Semaglutide
Numerous clinical studies have confirmed the efficacy of semaglutide, showing it can reduce glycated hemoglobin (HbA1c) by 1.5% to 1.8% in patients with type 2 diabetes. Its hypoglycemic effect surpasses that of liraglutide, exenatide weekly preparations, and sitagliptin.

Regardless of previous treatment methods or diabetes duration, semaglutide can significantly lower HbA1c, especially in patients with higher baseline levels. In domestic studies, 86.1% of patients reached their target HbA1c (<7%) after 30 weeks of treatment with semaglutide 1.0 mg/week.

Advantages of Semaglutide
1. Weight Loss Effect
Semaglutide not only lowers blood sugar but also aids in weight loss. Studies have shown significant weight reduction in diabetic patients using semaglutide. This weight loss is "smart," meaning it is more significant in those with a higher body mass index (BMI) and minimal in non-obese patients. Thus, even patients with a BMI under 25kg/m² can use it safely.

2. Low Risk of Hypoglycemia
The hypoglycemic action of semaglutide is blood sugar-dependent; it works more effectively at higher blood sugar levels and diminishes as blood sugar normalizes. Analyses indicate a very low risk of hypoglycemia among semaglutide users.

3. Cardiovascular Protection
In addition to its hypoglycemic and weight loss benefits, semaglutide offers cardiovascular protection. Similar to other GLP-1 receptor agonists like liraglutide and dulaglutide, semaglutide has been shown to reduce the risk of major adverse cardiovascular events. It lowers the risk of stroke by 39% and significantly reduces cardiovascular risks, making it ideal for patients with type 2 diabetes, cardiovascular disease, obesity, or kidney disease.

Integrating Levemir FlexTouch in Diabetes Management
For patients using Levemir FlexTouch, integrating semaglutide can further enhance diabetes management. The Levemir FlexTouch pen is an easy-to-use insulin delivery system that provides consistent and precise insulin dosing. Combining it with semaglutide's benefits can optimize blood sugar control and overall health outcomes.

Semaglutide, with its hypoglycemic potency, weight loss benefits, and cardiovascular protection, is a superior choice for managing type 2 diabetes. For those using Levemir FlexTouch, combining it with semaglutide can offer a comprehensive approach to diabetes care. As always, consult with healthcare professionals before making any changes to your diabetes management plan.

Comments

Post a Comment

Popular posts from this blog

Blood Sugar Lowering Exercises: Are You on Track?

  Exercise to lower blood sugar, you may have been doing it wrong Research results show that in men with type 2  diabetes , high-intensity interval training in the afternoon appeared to be better at improving blood sugar levels than exercising in the morning during the first two weeks of a training regimen. And when you exercise in the morning, your blood sugar control is slightly worse. This study data highlights the importance of optimizing exercise timing to improve glycemic control in type 2 diabetes. Therefore, people with diabetes should choose scientific and reasonable exercise and avoid the following "seven unsuitable" exercises to lower blood sugar. 1. It is not advisable to exercise when the following conditions occur: 1. Blood sugar >16.7 mmol/L or fluctuates greatly: 2. Acute complications of diabetes such as acute infection; 3. Severe diabetic nephropathy; 4. Retinopathy with fundus hemorrhage; 5. Diabetic foot; 6. Serious cardiovascular and cerebrovascular di...
Post a Comment
Read more

Diabetes in Seniors: 4 Crucial Management Differences

  The elderly are the main force among the diabetic population. When the house leaks and it rains all night long, elderly people with   diabetes   often suffer from diseases such as high blood pressure, dyslipidemia, coronary heart disease, and cerebral infarction. The body's metabolic capacity also deteriorates, and their eyesight and legs and feet are also less flexible. Therefore, in the view of our doctors, elderly people with diabetes are the key targets of protection and must be closely monitored. On the road to fighting against the devil, they are different from ordinary adult diabetic patients. One of the differences - eating: no need to deliberately lose weight Many elderly people with diabetes believe that they are too fat and their blood sugar is too high because of food, so they control their diet extremely harshly, causing their bodies to lose weight day by day. At this time, they are secretly happy, after all, "it is hard to buy old age to lose weight." ! Ye...
Post a Comment
Read more

Revolutionizing Therapy: Panacea's Next Leap - Unveiling the Future of Injection Pens

  Do you still have a sense of boundaries? I’m talking about semaglutide. On October 10, Novo Nordisk announced that the Phase III clinical trial of semaglutide in the treatment of kidney damage patients with type 2 diabetes and chronic kidney disease was terminated early due to excellent efficacy. GLP-1 drugs are becoming a panacea, from reducing blood sugar and weight to chronic kidney disease, NASH, Alzheimer's disease, Parkinson's disease, obstructive sleep apnea, intermittent claudication, dyslipidemia, and even improving psoriasis disease symptoms. In May this year, "Frontiers in Pharmacology" also discussed the treatment of GLP-1 for inflammatory bowel disease (IBD), mucositis, short bowel syndrome, acute lung injury, pulmonary fibrosis, and pulmonary hypertension. Who can withstand this? The GLP-1 industry chain has finally become fragrant and long, from downstream drugs (Innovent Biologics, Hengrui Pharmaceuticals, Huadong Medicine, Changshan Pharmaceuticals,...
Post a Comment
Read more